Defective TBXAS1 causes Ghosal hematodiaphyseal dysplasia (GHDD)

Stable Identifier
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser

Thromboxane-A synthase (TBXAS1), an enzyme of the arachidonic acid cascade, produces thromboxane A2 (TXA2) from prostaglandin H2 (PGH2). Together with prostacyclin (PGI2), TXA2 plays a key role in the maintenance of haemostasis. It is also a constrictor of vascular and respiratory smooth muscle and implicated in the induction of osteoclast differentiation and activation. Defects in TBXAS1 can cause Ghosal hematodiaphyseal dysplasia (GHDD; MIM:231095), a rare autosomal recessive disorder characterised by increased bone density with predominant diaphyseal involvement and aregenerative anemia, a bone marrow failure where functional marrow cells are regenerated slowly or not at all (Genevieve et al. 2008).

Literature References
PubMed ID Title Journal Year
18264100 Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)

Geneviève, D, Proulle, V, Isidor, B, Bellais, S, Serre, V, Djouadi, F, Picard, C, Vignon-Savoye, C, Bader-Meunier, B, Blanche, S, de Vernejoul, MC, Legeai-Mallet, L, Fischer, AM, Le Merrer, M, Dreyfus, M, Gaussem, P, Munnich, A, Cormier-Daire, V

Nat. Genet. 2008
Participant Of
Name Identifier Synonyms
anemia 2355
bone disease 0080001
Cross References
BioModels Database
Cite Us!